Government imports APIs worth Rs 28,529 crores in FY2020-21
The size of the API and Intermediates market in India is estimated to be Rs 96,000 crores in FY 2019-20
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
PLI scheme
PLI scheme to help India become Aatmanirbhar in APIs; boost investments in high-value generics: ICRA…
ICRA expects the above measures to strengthen the business profile of R&D-based Indian pharma companies and thus an increase…
PHDCCI urges government to extend support for vaccine industry
PHDCCI President Sanjay Aggarwal noted that although vaccines have been put under the biopharmaceuticals category, there is not…
Government issues operational guidelines for pharma PLI scheme
The applications are invited in the three groups based on the Global Manufacturing Revenue of FY 2019-20 of the applicant. A…
Four pharma firms get approval under PLI scheme for bulk drugs
Solara Active Pharma Science, Rajasthan Antibiotics, Dhatri Lab and Vital Laboratories received approval
Pharma firms with approval for projects under PLI scheme should start production at the earliest:…
This will enable India to provide pharma and medical devices products to domestic and global markets at competitive rates
Indian pharma exports register 18 per cent growth to touch $24.44 bn in FY 21
Pharma exports from India witnessed over 18 per cent growth to $24.44 billion during the last financial year against $20.58…
Industry maange more
Recently, the Ministry of Environment, Forest and Climate Change (MoEF) brought an amendment by bringing API and intermediates…
Aarti Speciality Chemicals gets approval under Pharma PLI Scheme
The approval is for 2-Methyl-5Nitro-Imidazole (2-MNI) with a committed production capacity of 4,000 MT per annum under Target…
Industry welcomes PLI 2.0 Scheme, awaits implementation details
Stakeholders highlight that this scheme will help play to our strengths, work towards making the pharma industry more…